Morgan Hardy

1 presentation

• T49. CONCURRENT ORAL ANTIDEPRESSANT USE AND CLINICAL OUTCOMES FROM INTRAVENOUS KETAMINE OR INTRANASAL ESKETAMINE IN A REAL-WORLD SAMPLE

  2026 ASCP Annual Meeting